Melatonin Side Effects: Next-Day Grogginess, Vivid Dreams and the Long-Term Questions

A friend texted at 7:40 on a Tuesday morning: “Took melatonin, slept fine, now I feel like I’m wading through wet sand. Is that normal?” Within the hour, three people in the same group chat had shared a headline about melatonin and heart failure. That is roughly how this story has gone in search since November 2025, when a preliminary study presented at the American Heart Association’s Scientific Sessions reported that adults with insomnia who had used melatonin for a year or longer had a higher rate of heart failure than those who had not.

As of January 2026, the study has not been published in a peer-reviewed journal, it was observational rather than a trial, and its own authors called the finding a reason to study the question, not a reason to panic. None of that nuance survives a screenshot.

So this is the long version: what melatonin side effects actually look like, why the groggy mornings and strange dreams happen, how strong the evidence is at each step, and what remains genuinely unanswered about taking it every night for years.

What changed recently: why melatonin side effects are trending

Three dated events explain the surge of interest, and they stack on top of one another.

The newest is the November 2025 heart-failure analysis. Researchers used a large electronic health record database to compare roughly 130,000 adults with insomnia, split by whether melatonin use had been documented for at least 12 months. Over about five years, heart failure was recorded in approximately 4.6% of long-term users versus 2.7% of non-users, a relative increase of around 90%. Hospitalisation for heart failure and death from any cause were also more common among users. The work was presented as a conference abstract; it has not yet passed peer review and it cannot show cause and effect. More on why in a later section.

The second thread is older but keeps resurfacing. In June 2022 the CDC’s Morbidity and Mortality Weekly Report described 260,435 pediatric melatonin ingestions reported to US poison centers between 2012 and 2021, a 530% rise across the decade. Most were accidental swallows by children under five, and most caused no symptoms, but 27,795 led to a healthcare visit and around 4,000 to a hospital stay. Those numbers are why gummy melatonin now comes up in nearly every conversation about child safety and supplements.

The third is product quality. A 2017 analysis of 31 melatonin supplements, published in the Journal of Clinical Sleep Medicine, found actual content ranging from 83% below to 478% above the label, with lot-to-lot swings as large as 465% in the same product. About a quarter contained serotonin, a neurotransmitter not listed on any label. In the United States melatonin is sold as a dietary supplement, a category the FDA does not test for content before sale, which is why these findings still matter. Put the three stories together and you get the current search spike: a new long-term question layered on top of long-standing doubts about who is taking what, and how much.

What melatonin actually does in the body

Melatonin is a hormone, a chemical messenger the body makes and releases into the blood to coordinate other tissues. The pineal gland, a pea-sized structure deep in the brain, releases it when light fades in the evening. Levels climb through the night and fall toward dawn. Its job is less “knock you out” and more “tell every clock in the body what time it is”. That timing system is the circadian rhythm, the roughly 24-hour cycle that governs sleepiness, body temperature, hormone release and alertness.

This distinction matters for understanding side effects. A sleeping pill in the classic sense dampens brain activity. Melatonin instead nudges the timing of sleep and modestly lowers alertness. That is why its measurable effect on falling asleep is small, why it works best when the body clock is out of step with the clock on the wall (jet lag, shift work, a delayed sleep phase), and why taking it at the wrong time can make the next day feel off.

Two more facts shape everything that follows. First, immediate-release melatonin has a half-life, the time for blood levels to fall by half, of roughly 40 to 60 minutes, so in theory it should be gone by morning. In practice, slow-release forms, higher amounts than the body makes, slower metabolism in older adults, and certain medicines can stretch its presence into daylight hours. Second, melatonin is metabolised mainly by a liver enzyme called CYP1A2. Anything that blocks that enzyme, including the antidepressant fluvoxamine and, to a lesser degree, some oral contraceptives, raises melatonin levels and can intensify drowsiness.

Knowing this, the side-effect list stops looking random. Grogginess, vivid dreams, headache and a flat mood are mostly what you would predict from a timing hormone lingering longer or arriving in larger quantities than the brain expects.

What are the most common melatonin side effects?

Across randomised trials and the side-effect data collected by the NHS, Mayo Clinic and the NIH’s National Center for Complementary and Integrative Health, the same short list keeps appearing.

• Daytime drowsiness or grogginess. The most consistently reported effect, especially with slow-release products or when taken late at night.
• Headache. Usually mild and dull; it tends to fade within a few days of continued use or on stopping.
• Dizziness or light-headedness. Melatonin can modestly lower blood pressure and body temperature overnight, which may explain this in some people.
• Nausea or stomach discomfort. More common on an empty stomach.
• Vivid dreams or nightmares. Less common, but the one people remember and search for.

A second tier is reported less often: short-lived low mood, irritability, mild anxiety, reduced alertness, confusion (more often in older adults), and in rare cases tremor or unusually low blood pressure. The NHS also lists dry mouth, and Mayo Clinic adds reduced appetite and bed-wetting in children.

How common is “common”? In the placebo-controlled trials pooled in systematic reviews, the rate of adverse events in melatonin groups is generally close to the placebo rate, and the gap is driven by daytime sleepiness and headache. Serious adverse events are rare in trials lasting up to a few months. That is a reassuring profile for short-term use. It is also, importantly, a profile built from short studies in selected volunteers, which is exactly why the long-term and everyday-user questions remain open.

One pattern deserves emphasis: side effects track timing and quantity. People who take melatonin in the middle of the night after waking, or who take more because “a little didn’t work”, report the next-day effects most often. The hormone is doing what a timing signal does when it arrives at the wrong hour.

Why does melatonin cause next-day grogginess?

The wet-sand feeling has three plausible mechanisms, and most mornings involve more than one.

The first is simple overhang. If melatonin levels are still elevated at wake-up, the brain is receiving a “night” signal in daylight. Immediate-release products clear within hours in a healthy younger adult, but slow-release forms are designed to keep levels up until early morning, and anything that delays clearance, such as older age, liver disease or an interacting medicine, extends that window. The amounts in many over-the-counter products are far higher than what the pineal gland releases on its own, so even a product that is “mostly gone” by morning may still be above the body’s natural daytime level.

The second mechanism is timing, not quantity. Melatonin shifts the body clock. Taken too late, it can push the clock later rather than earlier, so you wake at the alarm but your internal time says it is still the small hours. That mismatch feels like jet lag because, physiologically, it is a mild form of it. People who take melatonin after a 3 a.m. awakening are especially prone to this.

The third is that melatonin lowers core body temperature and blood pressure slightly during the night. Both normally rise as part of waking up. A blunted morning rise can leave people feeling sluggish and light-headed on standing, which is the dizziness some describe.

What helps, according to sleep specialists at major academic centers, is consistency: the same time each evening, taken before the planned bedtime rather than after lying awake, and not re-dosed during the night. If grogginess persists despite a steady routine, that is a signal to raise with a clinician rather than something to push through. Daytime drowsiness also matters for driving. Several guidance sources, including the NHS, advise against driving or operating machinery until you know how melatonin affects you, and that includes the morning after.

Melatonin and vivid dreams: what is actually happening?

Vivid, detailed, sometimes unsettling dreams are the melatonin side effect people describe with the most colour. Reddit threads are full of them. The scientific explanation is incomplete but not mysterious.

Rapid eye movement (REM) sleep is the stage in which most vivid dreaming occurs; the brain is highly active while the body is largely still. Several small studies suggest melatonin can modestly increase the proportion of time spent in REM, or make REM periods more consolidated. More REM, or REM that is denser, tends to mean more dream recall. Melatonin may also act on sleep architecture in a way that produces brief awakenings at the end of REM cycles, and a dream interrupted at its peak is a dream you remember.

A second factor is expectation and attention. People who start a new sleep aid pay closer attention to their sleep, and simply noticing dreams more can feel like dreaming more. This is not a dismissal; it is a reminder that dream recall is a poor measure of what the brain is actually doing.

Are the dreams harmful? For most adults, no. They are a nuisance that fades when melatonin is stopped, and for some they fade with continued use. The exceptions worth flagging are people with post-traumatic stress disorder or a history of nightmares, in whom more intense dreaming can be distressing, and anyone whose dreams come with acting out movements, shouting or falling out of bed. That pattern, called REM sleep behaviour disorder, needs medical assessment regardless of melatonin, because it can be an early sign of neurological conditions. Melatonin is sometimes prescribed for that disorder under specialist care, which illustrates how context changes everything.

The evidence here is graded low to moderate: small trials and polysomnography studies, plus a great deal of consistent anecdote. It is enough to say the effect is real for some people, and not enough to say exactly why.

What the evidence actually says, graded by strength

Evidence comes in tiers. A randomised controlled trial assigns people to melatonin or placebo by chance and is the strongest design for cause and effect. Observational studies watch what people already do and look for patterns; they are good for spotting signals and poor at proving causes. Expert opinion fills the gaps. Here is where melatonin stands on each key question.

Does it help sleep? Strong evidence that the effect is real and modest. A 2013 meta-analysis (a statistical pooling of trials) of 19 randomised studies found melatonin shortened the time to fall asleep by about seven minutes and lengthened total sleep by about eight minutes compared with placebo, with a small improvement in rated sleep quality. For jet lag and delayed sleep phase, the effects are larger and the evidence is moderate to strong. For chronic insomnia in adults, the American Academy of Sleep Medicine’s 2017 guideline issued a weak recommendation against routine use because the benefit was judged too small to be clinically meaningful for most people.

Is it safe short term? Strong evidence from trials lasting days to months: adverse events similar to placebo, serious harm rare.

Is it safe long term? Weak evidence, mostly because there is little of it. Few randomised trials extend beyond six months. Observational data, including the 2025 heart-failure analysis, raise questions that trials have not answered.

Is it safe for children? Moderate evidence of short-term tolerability in trials involving children with autism or ADHD; very limited data on healthy children and on years of use. Expert bodies describe the long-term effect on development as unknown.

Are products reliable? Moderate evidence that content varies widely, from the 2017 Journal of Clinical Sleep Medicine analysis and later testing of gummies.

If you take one thing from this grading, make it this: the strongest evidence supports a small benefit and good short-term tolerability. Everything about years of nightly use sits in the weakest tier.

Melatonin long term: is it bad to take it every night?

This is the question behind most of the searches, and the honest answer has two halves.

The reassuring half: there is no good evidence that nightly melatonin causes dependence in the way benzodiazepines or “Z-drugs” can. Tolerance, meaning needing more over time for the same effect, has not been convincingly shown in trials. Withdrawal insomnia on stopping is not a recognised pattern, although the original sleep problem usually returns because melatonin was never addressing its cause. In the United Kingdom, where melatonin is prescription-only, the NHS describes short courses as the licensed use for insomnia in older adults, with longer use possible under medical review for specific conditions.

The uncomfortable half: nobody has run the trial that would answer the question. The NIH’s National Center for Complementary and Integrative Health states plainly that the safety of long-term use is not established, and that research on years of nightly use is lacking. Specific uncertainties include whether sustained external melatonin alters the body’s own production (short-term studies suggest it does not, but long-term data are thin), whether it affects reproductive hormones over time (a theoretical concern from animal research and from melatonin’s seasonal role in other mammals), and whether the cardiovascular signal reported in 2025 reflects something real.

There is a middle position that most sleep clinicians would recognise. Nightly use for a defined reason under a clinician’s review, such as a diagnosed circadian rhythm disorder, is different from open-ended nightly use because sleep “feels better with it”. The first has a rationale and a monitoring plan. The second often means an untreated problem, whether that is insomnia, sleep apnoea, anxiety, pain, or a bedroom lit like an airport until midnight.

So: “bad” is the wrong word. “Unstudied” is the accurate one. If you have been taking melatonin every night for more than a few months, that is worth a conversation with the person who manages your health, not a reason to stop abruptly on your own and not a reason to ignore.

The heart-failure headline: what the 2025 study can and cannot show

Here is the study that triggered the current wave of concern, read carefully.

Researchers queried a multinational electronic health record database for adults with a diagnosis of insomnia and no prior heart failure. They compared people whose records documented melatonin use for 12 months or more with matched people who had no recorded melatonin use, then followed both groups for about five years. The melatonin group had roughly 90% higher relative risk of a new heart failure diagnosis, about three and a half times the rate of hospital admission for heart failure, and roughly double the all-cause mortality. The authors presented it at the American Heart Association’s Scientific Sessions in November 2025 as preliminary research.

Why it should not be read as proof that melatonin damages the heart:

• Documentation bias. Melatonin is over-the-counter in the United States, so most casual users never appear in a medical record. People whose use was documented for a year were likely those with more severe or more medically supervised insomnia, which is itself linked to heart disease.
• Confounding by indication. Chronic insomnia, depression, obesity, sleep apnoea and heavy alcohol use all raise heart failure risk and all push people toward sleep aids. Matching reduces but cannot remove these effects.
• Biological plausibility runs the other way. Small randomised trials have explored melatonin as a potential protective agent in heart failure and blood pressure, with mixed but not alarming results. Nothing in known physiology predicts a doubling of heart failure.
• Not peer-reviewed. Conference abstracts often change, sometimes substantially, before publication.

What the study does legitimately do is identify a question that deserves a proper answer. The responsible reading, which matches how cardiologists quoted in mainstream coverage framed it, is that long-term users should not stop on the strength of a headline, and should not assume “natural” equals “free of long-term consequence” either. Both halves of that sentence matter.

Is more melatonin better? The dose-creep problem

Walk down a supplement aisle and the melatonin shelf tells a story: amounts on labels have climbed steadily over the past two decades, and the largest numbers tend to sit at eye level. Sleep researchers have a name for the result: dose creep.

The physiology argues against it. The amount the pineal gland releases at night is tiny, and studies dating back to the 1990s at Massachusetts Institute of Technology found that quantities close to that natural level shifted the body clock as effectively as much larger ones, with fewer next-day effects. Beyond a certain point, more melatonin does not produce more sleep. It produces higher and longer-lasting blood levels, which is a recipe for the grogginess, headache and vivid dreams covered earlier. Receptors in the brain can also become less responsive when flooded, which may blunt the very timing signal people are after.

The 2017 content analysis makes the problem worse in an unpredictable direction. If a product can contain nearly five times what its label says, and a different bottle of the same brand can contain a fraction of that, then “I take the same amount every night” may not be true even when the routine is identical.

The question people type, whether a particular high-number product is “too much”, cannot be answered with a figure here, and should not be. The appropriate amount depends on age, the reason for taking it, timing, other medicines, and whether the product is immediate or slow release. Those are prescribing decisions. What can be said is that the evidence does not reward higher amounts, that many clinicians consider the largest consumer products to exceed what is needed for a circadian effect, and that someone who finds themselves escalating because “it stopped working” is better served by a sleep assessment than by a bigger gummy.

Treat the number on the bottle as a question for your clinician or pharmacist rather than a recommendation.

Why many doctors are lukewarm on melatonin

“Why don’t doctors like melatonin?” is a fair question, and the answer is less about dislike than about a mismatch between how it is sold and what it does.

The first reason is effect size. Seven minutes faster to sleep and eight more minutes asleep, averaged across trials, is real but small. For someone lying awake for an hour, it rarely feels like a solution. Clinicians see patients who have concluded that “nothing works” after melatonin disappointed them, when the better-supported treatment for chronic insomnia, cognitive behavioural therapy for insomnia (CBT-I), a structured programme that retrains sleep habits and thinking, was never offered.

The second is masking. Insomnia is a symptom with causes: sleep apnoea, restless legs, depression, chronic pain, thyroid disease, alcohol, medicines, shift work, menopause. A supplement that takes the edge off can delay recognising the cause for years. Sleep physicians regularly meet people who have used melatonin nightly for a decade and never had their loud snoring evaluated.

The third is regulatory. In the United States melatonin is a dietary supplement, so a physician cannot be confident what their patient is actually swallowing. In the UK, Australia and much of Europe it is a prescription medicine precisely so that content and indication are controlled. American doctors are advising on a product they cannot verify.

The fourth is the age spread. Melatonin is now the most common supplement given to children for sleep in the United States, and clinicians are uneasy about years of hormone exposure during development without data.

None of this makes melatonin useless. For jet lag, for a clearly delayed body clock, for certain neurological and developmental conditions under specialist care, many of the same doctors prescribe it readily. Their reservation is about the default setting: a hormone taken nightly, indefinitely, in unverified amounts, for an undiagnosed problem. Framed that way, the caution looks less like prejudice and more like ordinary medicine.

Melatonin side effects in children and teens

Children sit at the centre of the melatonin debate for two reasons: they are using it in record numbers, and the long-term questions matter most for a body that is still developing.

Short-term tolerability in trials is reasonably good. Most randomised studies in children involve autism spectrum disorder or ADHD, where sleep problems are common and melatonin is sometimes prescribed. Reported side effects in those trials mirror adults: morning sleepiness, headache, and occasionally mood changes or bed-wetting. In the UK, prescribed paediatric melatonin is reviewed regularly for exactly these effects.

The concerns are elsewhere. Melatonin interacts with the hormonal signalling that governs puberty in other mammals, and in humans natural melatonin levels fall as puberty approaches. Whether years of external melatonin could shift the timing of puberty is unknown; the NIH’s National Center for Complementary and Integrative Health lists it as an unanswered question, and the American Academy of Pediatrics advises that families talk with a paediatrician before starting and treat melatonin as a short-term tool alongside behavioural sleep strategies, not a substitute for them.

Then there is the gummy problem. The CDC’s 2022 report documented a tenfold rise in paediatric melatonin ingestions over a decade, most of them toddlers helping themselves to a product that looks and tastes like candy. Reported symptoms, when present, were mostly drowsiness, vomiting and agitation; a small number of children were admitted to intensive care and two deaths were reported in the ten-year window. Combined with the content variability already discussed, this is why child-resistant storage and treating melatonin as a medicine rather than a snack are no longer optional advice.

For teenagers, who commonly have a naturally delayed body clock, melatonin has a logical role, but the same caveats apply, with an extra one: evening screens and late caffeine often explain more of a teenager’s sleep problem than any hormone can fix. Any regular use in a child or teen belongs under a clinician’s supervision, with a plan for when it stops.

Drug interactions and who should be cautious

Because melatonin is sold beside vitamins, people rarely mention it to their doctor or pharmacist. It belongs on the medication list. Mayo Clinic, the NHS and MedlinePlus flag the following interactions and cautions.

• Sedatives and sleep medicines, including benzodiazepines, Z-drugs, some antihistamines and alcohol. Additive drowsiness and impaired coordination.
• Anticoagulants and antiplatelet drugs such as warfarin. Melatonin may modestly affect clotting; the combination warrants monitoring.
• Blood pressure medicines. Melatonin can lower blood pressure slightly, and some data suggest it may interfere with certain calcium channel blockers.
• Diabetes medicines. Melatonin can affect glucose regulation; readings may shift.
• Anticonvulsants. Some reports of increased seizure frequency in children with neurological disorders, though the evidence is mixed.
• Immunosuppressants. Melatonin may stimulate immune activity, a theoretical concern after transplant or in autoimmune disease.
• Fluvoxamine and other CYP1A2 inhibitors. These can raise melatonin levels many-fold, markedly increasing drowsiness. Oral contraceptives and heavy caffeine intake also influence the same enzyme.

Beyond interactions, groups where caution is advised include people with autoimmune conditions, those with depression (short-lived low mood is a reported effect), people with liver or kidney disease (slower clearance), older adults (confusion and falls), and anyone who is pregnant or breastfeeding, where safety data are insufficient.

Starting melatonin while on any regular medicine is a question for the prescriber or pharmacist, who can check the specific combination. The same applies to stopping: nothing in this article should be read as a reason to discontinue a prescribed medicine or a prescribed melatonin regimen without that conversation.

Melatonin side effects at a glance: how common, how strong the evidence

A single table captures what the preceding sections spread across several thousand words. “Frequency” reflects how often the effect appears in trials and pharmacovigilance reports relative to placebo; “evidence grade” reflects the design of the studies behind it.

Side effect or concern	How often reported	Likely mechanism	Evidence grade
Next-day drowsiness	Common, more with slow-release and late timing	Overhang of hormone levels; body-clock shift	Strong (randomised trials)
Headache	Common, usually mild	Unclear; vascular effects proposed	Strong (randomised trials)
Dizziness	Occasional	Slight overnight drop in blood pressure and temperature	Moderate
Nausea	Occasional	Direct gut effect; worse on empty stomach	Moderate
Vivid dreams, nightmares	Less common but memorable	Changes in REM sleep	Low to moderate
Low mood, irritability	Uncommon, short-lived	Unclear	Low (case reports, trial signals)
Confusion, falls in older adults	Uncommon	Slower clearance, sedation	Low to moderate
Dependence or tolerance	Not demonstrated	No addictive pathway identified	Moderate (absence of signal)
Heart failure with long-term use	Unknown	Unexplained; confounding likely	Very low (one unpublished observational study)
Effects on puberty or hormones	Unknown	Theoretical, from animal data	Very low

The pattern in the right-hand column is the point. The effects you can expect are well documented and mild; the effects that frighten people sit at the bottom of the evidence ladder, not because they have been disproven but because they have barely been studied. Those are different situations, and they call for different responses: manage the first, keep an open and watchful mind on the second.

Common myths about melatonin, corrected

Viral claims cluster around a few recurring errors.

Myth: “It’s natural, so it can’t have side effects.” Melatonin is natural in the sense that the body makes it. So are insulin, cortisol and oestrogen. A hormone taken in amounts and at times the body did not choose can produce effects, and the common ones are listed above.

Myth: “Melatonin is addictive.” No trial has shown physical dependence or withdrawal. What people experience on stopping is usually the return of the original sleep problem, which is a different thing and points to the need for a proper assessment.

Myth: “There is a new official warning that melatonin causes heart failure.” As of January 2026, no regulator has issued such a warning. The source is a single preliminary observational study presented at a conference in November 2025. It raised a question; it did not establish a cause.

Myth: “Taking it every night shuts down your own production.” Short-term studies have not found suppression of the body’s own melatonin after stopping. Long-term data are limited, so the honest statement is “not shown”, not “proven safe”.

Myth: “If a little helps, more helps more.” The circadian effect plateaus at modest amounts; larger amounts mainly extend blood levels into the morning. Dose creep buys side effects, not sleep.

Myth: “Melatonin is a sleeping pill.” It is a timing signal. That is why it is useful for jet lag and delayed sleep phase, and only modestly useful for insomnia driven by stress, pain or a racing mind.

Myth: “Gummies are a gentle option for kids.” Gummies are the format most often accidentally eaten by toddlers and among the formats with the widest content variability in testing. Format changes nothing about the hormone and quite a lot about the risk of accidental ingestion.

Myth: “Doctors are against melatonin.” Doctors prescribe it readily for the right indications. Their reservation is about indefinite, unsupervised nightly use for undiagnosed sleep problems.

When to see a doctor about melatonin side effects

Most melatonin side effects fade within days of stopping and do not need medical attention. Some situations do, and a few need urgent care.

Seek urgent medical help, or call your local poison control line, if:

• A child has swallowed melatonin that was not intended for them, even if they seem well; the CDC’s data show most ingestions are harmless but a minority need hospital care.
• There is fainting, a seizure, severe confusion, chest pain, a very slow or irregular heartbeat, or difficulty breathing after taking melatonin, particularly alongside alcohol or sedatives.
• Signs of a severe allergic reaction appear: swelling of the lips, tongue or throat, hives spreading rapidly, or wheezing.

Book a non-urgent appointment if:

• Next-day drowsiness, dizziness or headache persist for more than a week or two despite a consistent timing routine, or if drowsiness is affecting driving or work.
• Mood changes appear: new or worsening low mood, anxiety or irritability.
• Vivid dreams come with acting out movements, shouting or injury during sleep, which warrants assessment for REM sleep behaviour disorder regardless of melatonin.
• You have been taking melatonin nightly for more than a few months, or find yourself increasing the amount because it “stopped working”.
• You take any regular prescription medicine, especially anticoagulants, blood pressure or diabetes medicines, anticonvulsants, immunosuppressants or fluvoxamine.
• You are pregnant, breastfeeding, or considering melatonin for a child.
• Loud snoring, gasping during sleep, unrefreshing sleep despite adequate hours, leg discomfort at night, or daytime sleepiness that predates melatonin: these suggest a condition melatonin cannot address.

Bring the actual product to the appointment, including the label. Whether to continue, adjust, stop or switch to a different approach is a decision for the clinician who knows your history, and if melatonin was prescribed, changes should go through the prescriber. Stopping abruptly on the basis of a headline is not advised; neither is continuing indefinitely on the basis of habit.

Frequently asked questions

Is it bad to take melatonin every night?

Not demonstrably, but it is unstudied beyond a few months. Short-term trials show side effects close to placebo and no sign of dependence. The gap is long-term data: no randomised trial has followed nightly users for years, and one 2025 observational study raised a heart-failure question that remains unproven. Nightly use for a defined reason under clinician review is different from open-ended habit; the latter is worth discussing with your doctor.

Is melatonin safe long term?

The honest answer is that nobody knows with confidence. Expert bodies including the NIH’s complementary health center state that long-term safety has not been established. Known short-term effects are mild, and concerns about hormone suppression or puberty timing are theoretical. The right response is neither alarm nor complacency: review ongoing use with a clinician, especially after several months, and address the underlying sleep problem rather than relying on melatonin indefinitely.

What is the new warning on melatonin?

There is no new official regulatory warning as of January 2026. The headlines refer to a preliminary study presented at the American Heart Association’s Scientific Sessions in November 2025, which found that adults with insomnia who had documented melatonin use for a year or more had higher rates of heart failure. It was observational, not peer-reviewed, and cannot prove cause. Researchers called for further study, not for people to stop.

Is a high-dose melatonin product too much?

Often, yes, in the sense that it exceeds what is needed. The body-clock effect plateaus at modest amounts; larger quantities mainly extend blood levels into the morning, driving grogginess, headache and vivid dreams. Content testing also shows labels can be wildly inaccurate. The appropriate amount depends on age, purpose, timing and other medicines, so specific numbers belong in a conversation with your clinician or pharmacist, not in a search result.

Why do I feel groggy the morning after melatonin?

Because melatonin is a timing signal, and some of it is probably still telling your brain it is night. Slow-release forms, higher amounts, older age, liver conditions and interacting medicines all extend its presence. Taking it late, or after waking at 3 a.m., can also shift your body clock later so the alarm arrives at your internal midnight. Consistent early-evening timing helps; persistent grogginess should be raised with a doctor.

Why does melatonin give me vivid dreams or nightmares?

Small studies suggest melatonin can increase or consolidate REM sleep, the stage in which most vivid dreaming occurs, and may produce brief awakenings at the end of dream cycles, which boosts recall. The effect is harmless for most adults and fades on stopping. If dreams involve acting out movements, shouting or injury, see a clinician, since that pattern needs assessment for REM sleep behaviour disorder regardless of melatonin.

Why don't doctors like melatonin?

Most do not dislike it; they distrust how it is used. The measured benefit for insomnia is small, it can mask treatable causes such as sleep apnoea or depression, US supplement content is unverified, and children now use it in record numbers without long-term data. The same clinicians prescribe it readily for jet lag, delayed sleep phase and certain neurological conditions. Their caution targets indefinite, unsupervised nightly use.

Is melatonin safe for children and teenagers?

Short-term use appears reasonably well tolerated in trials, mostly in children with autism or ADHD, with morning sleepiness and headache the main effects. The unknowns are long-term: melatonin interacts with hormonal signalling involved in puberty, and years of use have not been studied. Paediatric bodies advise a doctor’s input first and behavioural sleep strategies alongside. Accidental gummy ingestion by toddlers is a documented and growing hazard, so store it as a medicine.

Does melatonin interact with other medicines?

Yes. Documented interactions include sedatives and alcohol (additive drowsiness), anticoagulants such as warfarin, blood pressure and diabetes medicines, anticonvulsants, immunosuppressants and fluvoxamine, which can raise melatonin levels many-fold. Oral contraceptives and caffeine also affect how it is cleared. Because it is sold as a supplement, people rarely report it; put it on your medication list and check any new combination with a pharmacist or prescriber.

Should I stop taking melatonin because of the heart study?

Not on the strength of that study alone, and not abruptly if it was prescribed. The finding is preliminary, observational and likely shaped by the fact that recorded long-term users had more severe insomnia, itself a cardiovascular risk. The sensible step is a review with your clinician: why you take it, whether the underlying sleep problem has been assessed, and whether continuing still makes sense for you.

References

• Melatonin: What You Need To Know (NIH National Center for Complementary and Integrative Health)
• Side effects of melatonin (NHS)
• Pediatric Melatonin Ingestions, United States, 2012–2021 (CDC MMWR)

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.